Arena Pharmaceuticals, Inc.

Other

Kura Oncology, Inc.

Unilever Plc

Unilever, N.v.

Yun Shan

William Lucas Betts, Iii

Marlon Carlos

Lee Alani Selvey

Zezhi Jesse Shao

Ryan M Hart

Deam Windate Given, Iii

Paul Maffuid

Anthony C Blackburn

Scott Stirn

Anna Shifrina

Wolfgang Robert Bergmann

Jaimie Karyn Rueter

Patricia Andres

Mrunalini Dhamdhere

Roger Paul Bakale

Song Chen

Xiufeng Sun

Yue Lu

Ana Rita Neves

Licheng Song

Catalina Ferrer

Kenneth K Liu

M Unilever Home & Personal Careusa Dhamdhere

WR Unilever Home & Personal Care Usa Bergmann

PW Unilever Home & Personal Care Usa Milczarek

Pawel Wlodzimierz Milczarek

Cheryl Anne Taylor

Trefor Anthony Evans

Elena Maria Barbuzzi

Stephen Wire

Marlon V Carlos

Deam Windate Iii Given

William L Iii Betts

TA Unilever Home & Personal Care Usa Evans

Elena MG Unilever Res Port Sunglight Barbuzzi

Cheryl A Unilever Research Port Sunlight Taylor

Stephen Unilever Research Port Sunlight Wire

The present disclosure relates to solid forms of Compound 1, or a pharmaceutically acceptable form thereof, a pharmaceutically acceptable salt of Compound 1, or pharmaceutically acceptable solvate thereof, pharmaceutical compositions comprising the same, methods of preparing the same, and methods of treating cancer dependent on a farnesylated protein, using the same.

Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same

The present invention relates to certain compositions of a 5-HTserotonin receptor modulator and methods for their preparation. The compositions disclosed herein are useful for increasing slow wave sleep, improving sleep consolidation, improving sleep maintenance and improving sleep quality, and for treating insomnia and related sleep disorders, dyssomnias, parasomnias and nonrestorative sleep and the like. The compositions disclosed herein are further useful for treating platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, thrombosis, asthma or symptoms thereof, agitation or symptoms thereof, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorders, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, diabetic-related disorders and progressive multifocal leukoencephalopathy and the like.

Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto

The present invention relates to certain compositions of a 5-HTserotonin receptor modulator and methods for their preparation. The compositions disclosed herein are useful for increasing slow wave sleep, improvise sleep consolidation, improving sleep maintenance and improving sleep quality, and for treating insomnia and related sleep disorders, dyssomnias, parasomnias and nonrestorative sleep and the like. The compositions disclosed herein are further useful for treating platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, thrombosis, asthma or symptoms thereof, agitation or symptoms thereof, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorders, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, diabetic-related disorders and progressive multifocal leukoencephalopathy and the like.

[object Object]

Salts of the 5-HT-receptor agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, and dosage forms comprising them that are useful for, inter alia, weight management.

Salts of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine with optically active acids, and pharmaceutical compositions comprising them that are useful for, inter alia, weight management.

Salts of lorcaserin with optically active acids

Growing community of inventors

San Diego, CA, United States of America

Yun Shan